Dendritic cells dictate the responsiveness to PD-L1 blockade in cancer

被引：0
|
作者：
Mayoux, M. [1 ]
Roller, A. [2 ]
Pulko, V [1 ]
Chen, S. [1 ]
Fransen, M. [3 ]
Kowanetz, M. [4 ]
Rommel, K. [1 ]
Matos, I [1 ]
Colombetti, S. [1 ]
Belousov, A. [5 ]
Karanikas, V [1 ]
Hegde, P. [4 ]
Chen, D. [4 ]
Mellman, I [4 ]
Umana, P. [1 ]
Perro, M. [1 ]
Ossendorp, F. [3 ]
Klein, C. [1 ]
Xu, W. [1 ]
机构：
[1] Roche Innovat Ctr Zurich, Schlieren, Switzerland
[2] Roche Innovat Ctr Basel, Basel, Switzerland
[3] Leiden Univ, Med Ctr, Leiden, Netherlands
[4] Genentech Inc, San Francisco, CA USA
[5] Roche Innovat Ctr Munich, Penzberg, Germany
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2018年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
T-40
引用
收藏
页码：22 / 23
页数：2
相关论文
共 50 条
  • [1] Dendritic cells dictate the responsiveness of PD-L1 blockade in cancer
    Mayoux, Maud
    Fransen, Marieke F.
    Roller, Andreas
    Matos, Ines
    Pulko, Vesna
    Karanikas, Vaios
    Umana, Pablo
    Klein, Christian
    Ossendorp, Ferry A.
    Xu, Wei
    CANCER RESEARCH, 2017, 77
  • [2] Dendritic cells dictate responses to PD-L1 blockade cancer immunotherapy
    Mayoux, Maud
    Roller, Andreas
    Pulko, Vesna
    Sammicheli, Stefano
    Chen, Stanford
    Sum, Eva
    Jost, Christian
    Fransen, Marieke F.
    Buser, Regula B.
    Kowanetz, Marcin
    Rommel, Karolin
    Matos, Ines
    Colombetti, Sara
    Belousov, Anton
    Karanikas, Vaios
    Ossendorp, Ferry
    Hegde, Priti S.
    Chen, Daniel S.
    Umana, Pablo
    Perro, Mario
    Klein, Christian
    Xu, Wei
    SCIENCE TRANSLATIONAL MEDICINE, 2020, 12 (534)
  • [3] Dendritic cells dictate responses to PD-L1 blockade cancer immunotherapy (vol 12, eaav7431, 2020)
    Mayoux, M.
    Roller, A.
    Pulko, V.
    Sammicheli, S.
    Chen, S.
    Sum, E.
    Jost, C.
    Fransen, M. F.
    Buser, R. B.
    Kowanetz, M.
    Rommel, K.
    Matos, I.
    Colombetti, S.
    Belousov, A.
    Karanias, V.
    Ossendorp, F.
    Hegde, P. S.
    Chen, D. S.
    Umana, P.
    Perro, M.
    Klein, C.
    Xu, W.
    SCIENCE TRANSLATIONAL MEDICINE, 2020, 12 (546)
  • [4] Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?
    Fei Tang
    Pan Zheng
    Cell & Bioscience, 8
  • [5] Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?
    Tang, Fei
    Zheng, Pan
    CELL AND BIOSCIENCE, 2018, 8
  • [6] Combination of PD-1/PD-L1 checkpoint blockade and dendritic cell therapy
    Nesselhut, J.
    Marx, D.
    Lange, H.
    Chang, R. Y.
    Nesselhut, T.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2018, 48 : 95 - 95
  • [7] PD-1/PD-L1 blockade in renal cell cancer
    Beckermann, Kathryn E.
    Johnson, Douglas B.
    Sosman, Jeffrey A.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2017, 13 (01) : 77 - 84
  • [8] PD-L1 on host cells is essential for PD-L1 blockade-mediated tumor regression
    Tang, Haidong
    Liang, Yong
    Anders, Robert A.
    Taube, Janis M.
    Qiu, Xiangyan
    Mulgaonkar, Aditi
    Liu, Xin
    Harrington, Susan M.
    Guo, Jingya
    Xin, Yangchun
    Xiong, Yahong
    Nham, Kien
    Silvers, William
    Hao, Guiyang
    Sun, Xiankai
    Chen, Mingyi
    Hannan, Raquibul
    Qiao, Jian
    Dong, Haidong
    Peng, Hua
    Fu, Yang-Xin
    JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (02): : 580 - 588
  • [9] THE IMMUNOLOGICAL EFFECT OF PD-L1 BLOCKADE ON DENDRITIC CELLS DERIVED FROM CHRONIC MYELOID LEUKEMIA
    Zhang, L. S.
    Li, L. J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 479 - 479
  • [10] Blockade of PD-L1 Enhances Cancer Immunotherapy by Regulating Dendritic Cell Maturation and Macrophage Polarization
    Sun, Nai-Yun
    Chen, Yu-Li
    Wu, Wen-Yih
    Lin, Han-Wei
    Chiang, Ying-Cheng
    Chang, Chi-Fang
    Tai, Yi-Jou
    Hsu, Heng-Cheng
    Chen, Chi-An
    Sun, Wei-Zen
    Cheng, Wen-Fang
    CANCERS, 2019, 11 (09)
12345